Screening epitopes on systemic lupus erythematosus autoantigens with a peptide array.

Area of Science:

• Immunology
• Autoimmunity
• Diagnostic Biomarkers

Background:

• Systemic lupus erythematosus (SLE) is a common autoimmune disease characterized by various autoantibodies.
• The specific epitopes targeted by these autoantibodies in SLE remain largely undefined.
• Accurate identification of autoantibody epitopes is crucial for developing precise diagnostic tools.

Purpose of the Study:

• To screen and identify specific binding epitopes for SLE-related autoantibodies.
• To evaluate the diagnostic potential of identified epitopes in SLE patients.
• To validate novel peptide-based biomarkers for SLE.

Main Methods:

• Epitope prediction using the Immune Epitope Database and Analysis Resource (IEDB) software on 12 SLE autoantigens.
• Synthesis of predicted epitopes into peptides for a peptide array.
• Detection of serum IgG from SLE patients and healthy controls using the peptide array, followed by ELISA validation.
• Analysis of diagnostic efficiency using ROC curves.

Main Results:

• Seventy-three potential epitopes were predicted using IEDB software.
• Four peptide antigens showed significantly upregulated autoantibody binding in SLE patients' serum (P < 0.05).
• These validated peptides include acidic ribosomal phosphoprotein (P0)-4, P0-11, DNA topoisomerase 1 (full length)-1, and U1-SnRNP 68/70 KDa-1, with ROC areas ranging from 0.90 to 0.93.

Conclusions:

• Specific peptide fragments can detect autoantibodies uniquely expressed in SLE serum.
• These identified peptide epitopes hold promise as potential markers for clinical auxiliary diagnosis of SLE.
• High diagnostic efficiency suggests these peptides could improve SLE detection and management.